This review highlights roles of non-coding RNAs in gene expression and cardiovascular diseases, suggesting they may serve as therapeutic targets.
Non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are crucial regulators of gene expression and cellular function, with significant implications for cardiovascular diseases (CVDs) [1, 5]. These molecules influence a wide range of processes, including heart development, cardiomyocyte differentiation, cardiac remodeling, and vascular homeostasis. This review provides a detailed summary of their roles in these processes, highlighting their potential as diagnostic and therapeutic targets for CVDs. Understanding the mechanisms through which ncRNAs operate offers the possibility of innovative therapeutic strategies and underscores their importance in cardiovascular research.
No takes yet. Share an insight, caveat, or question.
Elizaveta I Bon (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: